Eyebright Medical Technology Beijing Co Ltd (688050) - Net Assets
Based on the latest financial reports, Eyebright Medical Technology Beijing Co Ltd (688050) has net assets worth CN¥3.13 Billion CNY (≈ $457.52 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥4.76 Billion ≈ $697.26 Million USD) and total liabilities (CN¥1.64 Billion ≈ $239.74 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 688050 intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥3.13 Billion |
| % of Total Assets | 65.62% |
| Annual Growth Rate | 35.93% |
| 5-Year Change | 70.69% |
| 10-Year Change | N/A |
| Growth Volatility | 61.5 |
Eyebright Medical Technology Beijing Co Ltd - Net Assets Trend (2016–2025)
This chart illustrates how Eyebright Medical Technology Beijing Co Ltd's net assets have evolved over time, based on quarterly financial data. See 688050 days of operational coverage to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Eyebright Medical Technology Beijing Co Ltd (2016–2025)
The table below shows the annual net assets of Eyebright Medical Technology Beijing Co Ltd from 2016 to 2025. For live valuation and market cap data, see Eyebright Medical Technology Beijing Co stock valuation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥2.97 Billion ≈ $434.64 Million |
+12.75% |
| 2024-12-31 | CN¥2.63 Billion ≈ $385.47 Million |
+11.81% |
| 2023-12-31 | CN¥2.36 Billion ≈ $344.75 Million |
+22.70% |
| 2022-12-31 | CN¥1.92 Billion ≈ $280.98 Million |
+10.34% |
| 2021-12-31 | CN¥1.74 Billion ≈ $254.64 Million |
+12.44% |
| 2020-12-31 | CN¥1.55 Billion ≈ $226.47 Million |
+139.01% |
| 2019-12-31 | CN¥647.52 Million ≈ $94.75 Million |
+16.91% |
| 2018-12-31 | CN¥553.87 Million ≈ $81.05 Million |
+179.10% |
| 2017-12-31 | CN¥198.44 Million ≈ $29.04 Million |
+5.83% |
| 2016-12-31 | CN¥187.52 Million ≈ $27.44 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Eyebright Medical Technology Beijing Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 117119864138.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥1.15 Billion | 41.08% |
| Other Components | CN¥1.64 Billion | 58.92% |
| Total Equity | CN¥2.79 Billion | 100.00% |
Eyebright Medical Technology Beijing Co Ltd Competitors by Market Cap
The table below lists competitors of Eyebright Medical Technology Beijing Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Zensar Technologies Limited
NSE:ZENSARTECH
|
$1.10 Billion |
|
Shandong Fengyuan Chemical Co Ltd
SHE:002805
|
$1.10 Billion |
|
Gentherm Inc
NASDAQ:THRM
|
$1.10 Billion |
|
Shenzhen Strongteam Decoration Engineering Co Ltd
SHE:002989
|
$1.10 Billion |
|
Guangzhou Restaurants Group Co
SHG:603043
|
$1.10 Billion |
|
Platinum Asset Management Ltd
AU:PTM
|
$1.10 Billion |
|
Guangdong Shunkong Development Co Ltd
SHE:003039
|
$1.10 Billion |
|
IRPC Public Company Limited
BK:IRPC
|
$1.10 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Eyebright Medical Technology Beijing Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 2,409,498,353 to 2,788,736,482, a change of 379,238,129 (15.7%).
- Net income of 265,414,800 contributed positively to equity growth.
- Dividend payments of 89,459,607 reduced retained earnings.
- Other comprehensive income decreased equity by 182,445,575.
- Other factors increased equity by 385,728,511.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥265.41 Million | +9.52% |
| Dividends Paid | CN¥89.46 Million | -3.21% |
| Other Comprehensive Income | CN¥-182.45 Million | -6.54% |
| Other Changes | CN¥385.73 Million | +13.83% |
| Total Change | CN¥- | 15.74% |
Book Value vs Market Value Analysis
This analysis compares Eyebright Medical Technology Beijing Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.68x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 14.51x to 2.68x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | CN¥2.68 | CN¥38.91 | x |
| 2017-12-31 | CN¥1.61 | CN¥38.91 | x |
| 2018-12-31 | CN¥4.22 | CN¥38.91 | x |
| 2019-12-31 | CN¥4.37 | CN¥38.91 | x |
| 2020-12-31 | CN¥9.43 | CN¥38.91 | x |
| 2021-12-31 | CN¥8.85 | CN¥38.91 | x |
| 2022-12-31 | CN¥9.82 | CN¥38.91 | x |
| 2023-12-31 | CN¥11.21 | CN¥38.91 | x |
| 2024-12-31 | CN¥12.72 | CN¥38.91 | x |
| 2025-12-31 | CN¥14.50 | CN¥38.91 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Eyebright Medical Technology Beijing Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 9.52%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 17.90%
- • Asset Turnover: 0.38x
- • Equity Multiplier: 1.39x
- Recent ROE (9.52%) is above the historical average (8.07%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | -0.75% | -3.21% | 0.19x | 1.25x | CN¥-20.12 Million |
| 2017 | -2.07% | -5.49% | 0.27x | 1.39x | CN¥-23.95 Million |
| 2018 | 3.69% | 15.99% | 0.22x | 1.06x | CN¥-34.78 Million |
| 2019 | 10.80% | 34.16% | 0.28x | 1.11x | CN¥4.93 Million |
| 2020 | 6.36% | 35.36% | 0.17x | 1.08x | CN¥-55.25 Million |
| 2021 | 10.24% | 39.56% | 0.21x | 1.22x | CN¥3.96 Million |
| 2022 | 12.51% | 40.15% | 0.26x | 1.21x | CN¥46.68 Million |
| 2023 | 14.27% | 31.96% | 0.31x | 1.44x | CN¥91.01 Million |
| 2024 | 16.12% | 27.55% | 0.40x | 1.45x | CN¥147.45 Million |
| 2025 | 9.52% | 17.90% | 0.38x | 1.39x | CN¥-13.46 Million |
Industry Comparison
This section compares Eyebright Medical Technology Beijing Co Ltd's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $1,410,652,091
- Average return on equity (ROE) among peers: 8.38%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Eyebright Medical Technology Beijing Co Ltd (688050) | CN¥3.13 Billion | -0.75% | 0.52x | $1.10 Billion |
| Beijing Centergate Technologies Holding Co Ltd (000931) | $1.74 Billion | 2.80% | 1.18x | $467.27 Million |
| Blue Sail Medical Co Ltd (002382) | $78.81 Million | 42.94% | 2.95x | $825.68 Million |
| Andon Health Co Ltd (002432) | $2.84 Billion | 32.04% | 0.39x | $5.00 Billion |
| Allmed Medical Products Co Ltd Class A (002950) | $3.61 Billion | 6.89% | 0.55x | $909.99 Million |
| Guangzhou Improve Med Instrument (300030) | $772.70 Million | 5.97% | 0.14x | $281.42 Million |
| QITIAN Technology Group Co Ltd (300061) | $1.31 Billion | -57.79% | 0.64x | $722.27 Million |
| Shanghai Tofflon Science Tech (300171) | $2.08 Billion | 10.46% | 0.21x | $1.27 Billion |
| Truking Technology Ltd (300358) | $832.98 Million | 18.84% | 0.72x | $842.36 Million |
| Jiangxi Sanxin Medtec Co Ltd (300453) | $552.62 Million | 6.63% | 0.13x | $718.14 Million |
| Shenyang Xingqi Pharmaceutical Co Ltd (300573) | $290.70 Million | 15.03% | 0.44x | $1.31 Billion |
About Eyebright Medical Technology Beijing Co Ltd
Eyebright Medical Technology (Beijing) Co., Ltd. engages in development, production, and commercialization of ophthalmic medical devices in China and internationally. The company offers intraocular, trimmers, capsular tension ring, defocus lense, orthokeratology, and contact lenses in the areas of surgical treatment, myopia management, and consumer vision care. It also provides solutions for opht… Read more